CD3 2.86% $1.36 cd private equity fund iii

My brief analysis of the Merger Proposal Update is now...

  1. 105 Posts.
    lightbulb Created with Sketch. 48
    My brief analysis of the Merger Proposal Update is now published:

    > Concerning questions about the Merger Proposal Update details

    It is vital all CD1, CD2 and CD3 investors inform themselves of what is actually being proposed and vote accordingly.

    Tip: Every significant investor I know of is voting NO. However, as the majority of investors are likely ex-retail clients of the former Dixon Advisory, it's important they inform themselves accurately and actually vote.

    If you don't vote, your OPEN votes will be directed FOR the merger!!
 
watchlist Created with Sketch. Add CD3 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.